hexocyclium methylsulfate

Key facts

INN

hexocyclium methylsulfate

Brand

TRAL

Route

ORAL

Formulation

TABLET

Related patents

patent

US 12422364

Fluorescence spectral shape analysis for analyte recognition

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12329457

Hyperspectral imaging for early detection of Alzheimer's disease

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12331105

Broadly neutralizing antibodies against HIV

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12274735

IL-4-fusion formulations for treatment of central nervous system (CNS) tumors

Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12269872

Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and th

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12202886

Neutralizing antibodies to GP120 and their use

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12156912

Methods and compositions for inhibiting diseases of the central nervous system

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12146150

Rescue of central and peripheral neurological phenotype of friedreich's ataxia b

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is hexocyclium methylsulfate?

hexocyclium methylsulfate (TRAL), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for hexocyclium methylsulfate?

TRAL is a marketed brand name for hexocyclium methylsulfate. Check FDA Drugs@FDA for the current US label holder.